<DOC>
	<DOCNO>NCT03062072</DOCNO>
	<brief_summary>To assess chemotherapy related hyperglycemia non-diabetic patient , investigator assess incidence hyperglycemia analyze co-medications risk factor .</brief_summary>
	<brief_title>Emergence Chemotherapy Related Hyperglycemia nOn-diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Antineoplastic Agents</mesh_term>
	<criteria>Patients cancer ( colorectal , breast ) treat curative intent one malignant lymphoma expect achieve complete remission chemotherapy ( mainly , CHOP regimen ) Patients without history diabetes mellitus Normal glucose tolerance , define protocol Patients diabetes mellitus hyperglycemia , define protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>normoglycemia</keyword>
	<keyword>cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>Hyperglycemia Drug Induced</keyword>
</DOC>